RU2577711C2 - Компенсация на основе наклона, включающая вторичные выходные сигналы - Google Patents
Компенсация на основе наклона, включающая вторичные выходные сигналы Download PDFInfo
- Publication number
- RU2577711C2 RU2577711C2 RU2012157320/15A RU2012157320A RU2577711C2 RU 2577711 C2 RU2577711 C2 RU 2577711C2 RU 2012157320/15 A RU2012157320/15 A RU 2012157320/15A RU 2012157320 A RU2012157320 A RU 2012157320A RU 2577711 C2 RU2577711 C2 RU 2577711C2
- Authority
- RU
- Russia
- Prior art keywords
- analyte
- output signal
- concentration
- index function
- sample
- Prior art date
Links
- 239000012491 analyte Substances 0.000 claims abstract description 146
- 239000000523 sample Substances 0.000 claims abstract description 135
- 238000005534 hematocrit Methods 0.000 claims abstract description 63
- 238000000034 method Methods 0.000 claims abstract description 49
- 239000012472 biological sample Substances 0.000 claims abstract description 31
- 230000004044 response Effects 0.000 claims abstract description 24
- 230000009897 systematic effect Effects 0.000 claims description 85
- 210000004369 blood Anatomy 0.000 claims description 32
- 239000008280 blood Substances 0.000 claims description 32
- 238000012360 testing method Methods 0.000 claims description 31
- 238000006722 reduction reaction Methods 0.000 claims description 18
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 230000007717 exclusion Effects 0.000 claims description 5
- 230000003993 interaction Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 8
- 238000006479 redox reaction Methods 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 238000004458 analytical method Methods 0.000 description 37
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 34
- 239000008103 glucose Substances 0.000 description 34
- 230000003287 optical effect Effects 0.000 description 22
- 238000005259 measurement Methods 0.000 description 19
- 239000013060 biological fluid Substances 0.000 description 15
- 239000004020 conductor Substances 0.000 description 14
- 230000009467 reduction Effects 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- 238000003556 assay Methods 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000010606 normalization Methods 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000004082 amperometric method Methods 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 238000012937 correction Methods 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 238000003869 coulometry Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 238000004832 voltammetry Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 101100364969 Dictyostelium discoideum scai gene Proteins 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 101100364971 Mus musculus Scai gene Proteins 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000012067 mathematical method Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- -1 for example Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48714—Physical analysis of biological material of liquid biological material by electrical means for determining substances foreign to the organism, e.g. drugs or heavy metals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35198810P | 2010-06-07 | 2010-06-07 | |
| US61/351,988 | 2010-06-07 | ||
| PCT/US2011/038329 WO2011156152A1 (en) | 2010-06-07 | 2011-05-27 | Slope-based compensation including secondary output signals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012157320A RU2012157320A (ru) | 2014-07-20 |
| RU2577711C2 true RU2577711C2 (ru) | 2016-03-20 |
Family
ID=44501672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012157320/15A RU2577711C2 (ru) | 2010-06-07 | 2011-05-27 | Компенсация на основе наклона, включающая вторичные выходные сигналы |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9164076B2 (enExample) |
| EP (3) | EP3431986A1 (enExample) |
| JP (1) | JP5856154B2 (enExample) |
| KR (2) | KR102068949B1 (enExample) |
| CN (1) | CN103210310B (enExample) |
| BR (1) | BR112012031166A2 (enExample) |
| CA (1) | CA2798938C (enExample) |
| ES (1) | ES2700100T3 (enExample) |
| MX (2) | MX340921B (enExample) |
| RU (1) | RU2577711C2 (enExample) |
| SG (2) | SG186179A1 (enExample) |
| WO (1) | WO2011156152A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8529751B2 (en) * | 2006-03-31 | 2013-09-10 | Lifescan, Inc. | Systems and methods for discriminating control solution from a physiological sample |
| US8778168B2 (en) | 2007-09-28 | 2014-07-15 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
| US8603768B2 (en) * | 2008-01-17 | 2013-12-10 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| US8551320B2 (en) | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| MX2012010860A (es) | 2010-03-22 | 2013-03-05 | Bayer Healthcare Llc | Compensacion residual para un biosensor. |
| KR102068949B1 (ko) * | 2010-06-07 | 2020-01-21 | 바이엘 헬쓰케어 엘엘씨 | 2차 출력 신호를 포함하는 기울기-기반 보상 |
| EP2758039B1 (en) | 2011-09-21 | 2018-01-24 | Ascensia Diabetes Care Holdings AG | Biosensor with error compensation |
| US9903830B2 (en) | 2011-12-29 | 2018-02-27 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte |
| US8709232B2 (en) * | 2012-04-30 | 2014-04-29 | Cilag Gmbh International | Analyte measurement technique and system |
| US9164056B2 (en) | 2012-07-27 | 2015-10-20 | Bayer Healthcare Llc | System and method for detecting used and dried sensors |
| EP3276355B1 (en) * | 2013-03-14 | 2020-05-06 | Ascensia Diabetes Care Holdings AG | Normalized calibration of analyte concentration determinations |
| CN105283765B (zh) * | 2013-03-14 | 2018-01-16 | 安晟信医疗科技控股公司 | 分析物浓度测定的系统误差补偿 |
| US9243276B2 (en) | 2013-08-29 | 2016-01-26 | Lifescan Scotland Limited | Method and system to determine hematocrit-insensitive glucose values in a fluid sample |
| US9459231B2 (en) | 2013-08-29 | 2016-10-04 | Lifescan Scotland Limited | Method and system to determine erroneous measurement signals during a test measurement sequence |
| JP6789246B2 (ja) * | 2015-05-15 | 2020-11-25 | アセンシア・ダイアベティス・ケア・ホールディングス・アーゲーＡｓｃｅｎｓｉａ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｈｏｌｄｉｎｇｓ ＡＧ | 改善されたバイオセンサシステム検体測定 |
| CN105021805B (zh) * | 2015-08-21 | 2018-03-06 | 三诺生物传感股份有限公司 | 一种人体生理参数检测结果的校正方法 |
| EP3485265B1 (en) | 2016-07-12 | 2025-03-12 | Ascensia Diabetes Care Holdings AG | Method for electrochemical analysis by use of alternating output signals from two electrodes |
| WO2018104835A1 (en) | 2016-12-05 | 2018-06-14 | Ascensia Diabetes Care Holdings Ag | Risk factor monitoring |
| CN113490454A (zh) | 2019-02-05 | 2021-10-08 | 安晟信医疗科技控股公司 | 用于探测连续分析物感测及自动更正的传感器操作的设备及方法 |
| US11666253B2 (en) | 2019-02-22 | 2023-06-06 | Ascensia Diabetes Care Holdings Ag | Methods and apparatus for analyte concentration monitoring using harmonic relationships |
| US11678820B2 (en) | 2019-09-10 | 2023-06-20 | Ascensia Diabetes Care Holdings Ag | Methods and apparatus for information gathering, error detection and analyte concentration determination during continuous analyte sensing |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2305279C2 (ru) * | 1995-11-16 | 2007-08-27 | Лайфскен, Инк. | Устройство и способ для определения концентрации восстановленной формы или окисленной формы окислительно-восстановительного вещества в жидкой пробе |
| WO2008036516A1 (en) * | 2006-09-22 | 2008-03-27 | Bayer Healthcare Llc | Biosensor system having enhanced stability and hematocrit performance |
| WO2009108239A2 (en) * | 2007-12-10 | 2009-09-03 | Bayer Healthcare Llc | Slope-based compensation |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US4750496A (en) | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
| US5243516A (en) | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| US5508171A (en) | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
| FR2701117B1 (fr) | 1993-02-04 | 1995-03-10 | Asulab Sa | Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose. |
| US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5620579A (en) | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| US5723284A (en) | 1996-04-01 | 1998-03-03 | Bayer Corporation | Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
| ATE227844T1 (de) | 1997-02-06 | 2002-11-15 | Therasense Inc | Kleinvolumiger sensor zur in-vitro bestimmung |
| US6391558B1 (en) | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
| US5798031A (en) | 1997-05-12 | 1998-08-25 | Bayer Corporation | Electrochemical biosensor |
| US6391645B1 (en) | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| WO1998058250A2 (en) | 1997-06-16 | 1998-12-23 | Elan Corporation, Plc | Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods |
| EP1042667B1 (en) | 1997-12-22 | 2009-06-17 | Roche Diagnostics Operations, Inc. | Meter |
| US7494816B2 (en) * | 1997-12-22 | 2009-02-24 | Roche Diagnostic Operations, Inc. | System and method for determining a temperature during analyte measurement |
| CA2311487C (en) | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Signal processing for measurement of physiological analytes |
| JP4256588B2 (ja) | 1998-05-20 | 2009-04-22 | アークレイ株式会社 | 統計的手法を用いた電気化学的測定方法および測定装置 |
| US6475372B1 (en) | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| WO2001021827A1 (en) | 1999-09-20 | 2001-03-29 | Roche Diagnostics Corporation | Small volume biosensor for continuous analyte monitoring |
| JP4050434B2 (ja) | 1999-11-29 | 2008-02-20 | 松下電器産業株式会社 | サンプルの弁別方法 |
| US7351323B2 (en) | 2001-01-17 | 2008-04-01 | Arkray, Inc. | Quantitative analyzing method and quantitative analyzer using sensor |
| WO2003034055A1 (en) | 2001-10-12 | 2003-04-24 | Arkray, Inc. | Concentration measuring method and concentration measuring device |
| AU2003234944A1 (en) | 2002-08-27 | 2004-03-18 | Bayer Healthcare, Llc | Methods of Determining Glucose Concentration in Whole Blood Samples |
| US7132041B2 (en) | 2003-02-11 | 2006-11-07 | Bayer Healthcare Llc | Methods of determining the concentration of an analyte in a fluid test sample |
| US7488601B2 (en) | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| US7452457B2 (en) * | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| CA2535833C (en) | 2003-08-21 | 2013-11-26 | Agamatrix, Inc. | Method and apparatus for assay of electrochemical properties |
| JP4449431B2 (ja) | 2003-11-19 | 2010-04-14 | パナソニック株式会社 | 基質濃度の測定方法 |
| JP2005156316A (ja) | 2003-11-25 | 2005-06-16 | Toshiba Corp | マイクロ波式濃度計 |
| JP4814110B2 (ja) * | 2004-02-06 | 2011-11-16 | バイエル・ヘルスケア・エルエルシー | 電気化学的バイオセンサ |
| WO2005103669A1 (ja) | 2004-04-19 | 2005-11-03 | Matsushita Electric Industrial Co., Ltd. | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
| EP1742054A4 (en) | 2004-04-28 | 2008-01-16 | Japan Science & Tech Agency | METHOD FOR PRODUCING BIOPUCE; BIOCHIP; BIOPUCE ANALYSIS DEVICE; BIOPUCE ANALYSIS METHOD |
| JP5065013B2 (ja) | 2004-05-14 | 2012-10-31 | バイエル・ヘルスケア・エルエルシー | グルコースアッセイにおいてヘマトクリットの調整を行う方法、およびそのための装置 |
| WO2006042304A1 (en) | 2004-10-12 | 2006-04-20 | Bayer Healthcare Llc | Concentration determination in a diffusion barrier layer |
| GB0501826D0 (en) | 2005-01-28 | 2005-03-09 | Melys Diagnostics Ltd | Apparatus for measurement of analyte concentration |
| US20090067150A1 (en) | 2005-03-22 | 2009-03-12 | Tomoaki Ito | Protection Film for Preventing Leakage of Information, Portable Pouch, Card Case, and Information-Leakage Preventing Plate |
| US7517439B2 (en) | 2005-04-15 | 2009-04-14 | Agamatrix, Inc. | Error detection in analyte measurements based on measurement of system resistance |
| BRPI0613592A2 (pt) | 2005-07-20 | 2011-01-18 | Bayer Healthcare Llc | amperometria conectada por porta |
| WO2007014231A1 (en) | 2005-07-26 | 2007-02-01 | Bayer Healthcare Llc | Method and system for checking an electromechanical biosensor |
| WO2007040913A1 (en) | 2005-09-30 | 2007-04-12 | Bayer Healthcare Llc | Gated voltammetry |
| ES2791724T3 (es) | 2006-02-27 | 2020-11-05 | Ascensia Diabetes Care Holdings Ag | Medida de analito ajustada en temperatura para sistemas de biosensor |
| RU2465812C2 (ru) | 2006-05-08 | 2012-11-10 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Система детектирования аномального выходного сигнала для биосенсора |
| JP5018777B2 (ja) * | 2006-07-05 | 2012-09-05 | パナソニック株式会社 | 液体試料測定方法および装置 |
| US20080248581A1 (en) | 2007-04-06 | 2008-10-09 | Bayer Healthcare Llc | Method for performing correction of blood glucose assay bias using blood hemoglobin concentration |
| CN101214152A (zh) * | 2008-01-22 | 2008-07-09 | 天津市先石光学技术有限公司 | 人体血糖浓度的微创、动态、连续检测方法 |
| WO2010077660A1 (en) * | 2008-12-08 | 2010-07-08 | Bayer Healthcare Llc | Biosensor system with signal adjustment |
| KR102068949B1 (ko) * | 2010-06-07 | 2020-01-21 | 바이엘 헬쓰케어 엘엘씨 | 2차 출력 신호를 포함하는 기울기-기반 보상 |
-
2011
- 2011-05-27 KR KR1020197010911A patent/KR102068949B1/ko active Active
- 2011-05-27 EP EP18190634.8A patent/EP3431986A1/en not_active Withdrawn
- 2011-05-27 EP EP16180262.4A patent/EP3104176B1/en active Active
- 2011-05-27 CN CN201180039221.4A patent/CN103210310B/zh active Active
- 2011-05-27 SG SG2012089371A patent/SG186179A1/en unknown
- 2011-05-27 MX MX2012014282A patent/MX340921B/es active IP Right Grant
- 2011-05-27 SG SG10201507109TA patent/SG10201507109TA/en unknown
- 2011-05-27 EP EP11730482.4A patent/EP2577302B8/en active Active
- 2011-05-27 BR BR112012031166A patent/BR112012031166A2/pt not_active IP Right Cessation
- 2011-05-27 US US13/117,872 patent/US9164076B2/en active Active
- 2011-05-27 KR KR1020137000447A patent/KR101971233B1/ko active Active
- 2011-05-27 ES ES16180262T patent/ES2700100T3/es active Active
- 2011-05-27 WO PCT/US2011/038329 patent/WO2011156152A1/en not_active Ceased
- 2011-05-27 CA CA2798938A patent/CA2798938C/en not_active Expired - Fee Related
- 2011-05-27 MX MX2016005536A patent/MX369764B/es unknown
- 2011-05-27 RU RU2012157320/15A patent/RU2577711C2/ru active
- 2011-05-27 JP JP2013514206A patent/JP5856154B2/ja active Active
-
2015
- 2015-09-04 US US14/846,174 patent/US9995702B2/en active Active
-
2018
- 2018-05-22 US US15/986,539 patent/US10921278B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2305279C2 (ru) * | 1995-11-16 | 2007-08-27 | Лайфскен, Инк. | Устройство и способ для определения концентрации восстановленной формы или окисленной формы окислительно-восстановительного вещества в жидкой пробе |
| WO2008036516A1 (en) * | 2006-09-22 | 2008-03-27 | Bayer Healthcare Llc | Biosensor system having enhanced stability and hematocrit performance |
| WO2009108239A2 (en) * | 2007-12-10 | 2009-09-03 | Bayer Healthcare Llc | Slope-based compensation |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20130109088A (ko) | 2013-10-07 |
| EP2577302B1 (en) | 2016-08-03 |
| EP3104176A1 (en) | 2016-12-14 |
| HK1181850A1 (en) | 2013-11-15 |
| US20110301857A1 (en) | 2011-12-08 |
| EP3104176B1 (en) | 2018-08-29 |
| EP2577302A1 (en) | 2013-04-10 |
| US20150377819A1 (en) | 2015-12-31 |
| CN103210310B (zh) | 2015-03-18 |
| US10921278B2 (en) | 2021-02-16 |
| WO2011156152A1 (en) | 2011-12-15 |
| KR101971233B1 (ko) | 2019-04-22 |
| MX340921B (es) | 2016-08-01 |
| MX2012014282A (es) | 2013-01-24 |
| RU2012157320A (ru) | 2014-07-20 |
| US20180275089A1 (en) | 2018-09-27 |
| CA2798938A1 (en) | 2011-12-15 |
| EP2577302B8 (en) | 2016-10-26 |
| CN103210310A (zh) | 2013-07-17 |
| KR20190042767A (ko) | 2019-04-24 |
| CA2798938C (en) | 2018-08-07 |
| SG186179A1 (en) | 2013-01-30 |
| SG10201507109TA (en) | 2015-10-29 |
| EP3431986A1 (en) | 2019-01-23 |
| MX369764B (es) | 2019-11-21 |
| US9164076B2 (en) | 2015-10-20 |
| BR112012031166A2 (pt) | 2018-02-27 |
| JP2013528289A (ja) | 2013-07-08 |
| US9995702B2 (en) | 2018-06-12 |
| ES2700100T3 (es) | 2019-02-14 |
| KR102068949B1 (ko) | 2020-01-21 |
| JP5856154B2 (ja) | 2016-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2577711C2 (ru) | Компенсация на основе наклона, включающая вторичные выходные сигналы | |
| RU2509304C2 (ru) | Биосенсорная система с корректировкой сигнала | |
| RU2546012C2 (ru) | Компенсация на основе наклона | |
| RU2566382C2 (ru) | Система управления недостаточным заполнением для биосенсора | |
| JP2012511160A5 (enExample) | ||
| JP2013528289A5 (enExample) | ||
| CN105308461B (zh) | 样品分析物浓度的逐次逼近法 | |
| HK1181850B (en) | Slope-based compensation including secondary output signals | |
| HK1220769B (en) | Progressive approximation of sample analyte concentration |